SCHEMBL22894072

SCHEMBL22894072

c1ccc(-c2nc(-c3ccc4c(c3)oc3ccc5ccccc5c34)nc(-n3c4ccccc4c4cc(-c5ccc6c(c5)c5ccccc5n6-c5ccccc5)ccc43)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.36
KDM4E B2RXH2 2/20 0.36
ATM Q13315 1/20 0.36
ABCG2 Q9UNQ0 4/20 0.35
PAX8 Q06710 2/20 0.35
CYP1A1 P04798 1/20 0.35
CYP1A2 P05177 1/20 0.35
FYN P06241 1/20 0.35
MAPK3 P27361 1/20 0.35
AHR P35869 1/20 0.35
SIRT2 Q8IXJ6 1/20 0.34
SIRT1 Q96EB6 1/20 0.34
PTGER4 P35408 1/20 0.34
PTGES O14684 1/20 0.34
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
USP2 O75604 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22893795 0.97 KDM4E (0.34) L3MBTL1KDM4EATMABCG2PAX8
SCHEMBL22893779 0.94 L3MBTL1 (0.36) L3MBTL1KDM4EATMABCG2PAX8
SCHEMBL22893773 0.94 KDM4E (0.38) L3MBTL1KDM4EATMABCG2PAX8
SCHEMBL22893792 0.93 ABCG2 (0.36) L3MBTL1KDM4EATMABCG2PAX8
SCHEMBL22893780 0.93 ABCG2 (0.36) L3MBTL1KDM4EATMABCG2PAX8
SCHEMBL24153603 0.92 ABCG2 (0.40) L3MBTL1KDM4EABCG2PAX8CYP1A1
SCHEMBL22893782 0.92 SIRT2 (0.34) L3MBTL1KDM4EATMABCG2PAX8
SCHEMBL22894171 0.91 SIRT2 (0.36) L3MBTL1KDM4EATMABCG2PAX8
SCHEMBL21573684 0.91 L3MBTL1 (0.42) L3MBTL1KDM4EATMABCG2SIRT2
SCHEMBL23981235 0.91 L3MBTL1 (0.44) L3MBTL1KDM4EATMABCG2PAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210013411-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2021-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210013411-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 L3MBTL1 1367/4885KDM4E 2673/4885ATM 3135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.